Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/8403706
CITATIONS
READS
131
33
4 AUTHORS, INCLUDING:
Lakshman Perera Samaranayake
University of Queensland
558 PUBLICATIONS 10,732 CITATIONS
SEE PROFILE
KEYWORDS
Candida albicans;
Adhesion;
Biofilm;
XTT reduction assay;
ATP bioluminescence
Introduction
Candida species are considered important opportunistic pathogens due to the increasing frequency of
infections they cause in compromised patient groups
such as those on cancer chemotherapy, broad-spectrum antibiotics, and HIV-infected individuals. Of the
many pathogenic Candida species, Candida albicans
is the major fungal pathogen of humans.1 In the oral
*
cavity, a niche they frequently inhabit as commensals, these yeasts exist predominantly within biofilms, which are spatially organised heterogeneous
communities of fungal cells encased in a matrix of
extracelluar polymeric substances (EPS).2,3 Candida
biofilms can also develop on surfaces of prosthesis
and medical devices, and exhibit resistance to both
antifungals and host defenses compared with their
free-living planktonic counterparts. This is likely to
be the cause of recalcitrant persistence of Candida
on inert, inserted surfaces or, superficial mucosae.3
Once a prosthesis is placed in the oral cavity, it
will be instantaneously coated with a pellicle of
00039969/$ see front matter 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.archoralbio.2004.04.011
790
Y. Jin et al.
791
Adhesion assay
Biofilm formation
Saliva collection
Whole unstimulated saliva was collected from five
healthy adult volunteers who were asked not to eat
before 2 h prior to collection. The saliva donors
were also asked to rinse their mouths gently with
water before sampling to decrease bacterial contamination. Saliva was collected on ice for 10 min,
pooled and centrifuged at 12 000 g for 15 min at
4 8C. The resulting supernatant was immediately
stored at 70 8C until used.5,21 Saliva samples collected using an analogous protocol have been
demonstrated to contain most salivary contents
associated with microbial adhesion and biofilm formation, such as proline-rich proteins, mucins, and a
variety of enzymes.21
Saliva assay
Figure 1 A flow chart illustrating the experimental steps
of the study. OD: optical density measurement; PBS:
phosphate buffered saline; XTT: tetrazolium salt 2,3-bis
(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay;
ATP: adenosine triphosphate ATP bioluminescence assay;
CFU: colony forming unit.
792
Y. Jin et al.
Statistical analyses
The statistical analyses were performed using SPSS
11.0 for windows. One-way ANOVA was performed
to analyse the differences among multiple means.
According to the tests of homogeneity of variances,
either Bonferroni or Dunnett T3-test was carried out
for post-hoc multiple comparisons. P-values of
<0.05 were considered statistically significant.
Results
Evaluation of quantitative methods used in
this study
To be able to predict cell concentration using the
ATP index, a standard curve was generated for these
two parameters using C. albicans 192 887 g (Fig. 2).
On regression analysis a coefficient of correlation of
0.999 and P < 0.0001 were noted, indicating that
the yeast cell numbers in suspension can be con-
Figure 2 The relationship between ATP bioluminescence and cell concentrations of C. albicans determined
by a hemocytometer. Linear regression analysis revealed
perfect linearity between the log10 ATP concentration
and log10 cell number (r 0.999; P < 0.0001). Regression
formula was as follows: lg Cell concentration 1.0947
lg ATP concentration 3.9567. The isolate used was
192 887 g.
fidently predicted using the ATP method in combination with the generated standard curve.
Another quantitative technique used in the present study was the XTT reduction assay which has
been extensively used for biofilm quantification.16,23,24 Since both the ATP and the XTT assays
are based on metabolic activity which may vary in
planktonic and biofilm phase cells,25 we further
compared these two methods with the CFU values
of the resuspended biofilm cells, as the latter is
unlikely to be significantly affected by the metabolic state of the cells. For this purpose, Candida
biofilms were formed on either nude or salivacoated surfaces in glucose- or galactose-supplemented media and the cell mass quantified either
using the XTT, ATP or the CFU assays. As shown in
Fig. 3ac, there were no significant variations in
cell mass when quantified by any of the three
assays. Additionally, on regression analyses significant correlations were also noted between the
three methods (XTT versus ATP r 0.980;
P 0.02; XTT versus CFU r 0.985; P 0.015;
CFU versus ATP r 0.994; P 0.006) (Fig. 4).
793
794
Y. Jin et al.
Figure 3 Biofilm formations of C. albicans 192 887 g in a medium containing either 100 mM glucose or 500 mM
galactose and in the absence or the presence of a mixed saliva coating. The methods used for biofilm quantification
were XTT reduction assay (a), ATP bioluminescence assay (b) and CFU evaluation (c). Data are means standard
deviations of three independent experiments performed in triplicate.
Discussion
A variety of methods have been recently used in
quantification of Candida biofilms on different substrata. These include XTT, ATP, crystal violet absor-
795
planktonic yeasts (r 0.999, P < 0.0001), concurring with the findings of others.28 Our previous
studies have also demonstrated that XTT activity
is linearly associated with cell numbers and hence a
reliable method for biofilm quantification.16 It is
however noteworthy that biofilm cells, which are
encased within an EPS matrix, may possibly have
limited access to nutrients and oxygen, resulting in
796
Y. Jin et al.
Acknowledgements
This work described in this paper was partially
supported by a Grant from the Research Grants
Council of the Hong Kong Special Administrative
Region of China (HKU7013/99M) and a grant from
the Committee of Research and Conference Grants
(a/c 10203775) of the University of Hong Kong.
References
1. Samaranayake LP, Lamb AB, Lamey PJ, MacFarlane TW. Oral
carriage of Candida species and coliforms in patients with
burning mouth syndrome. J Oral Pathol Med 1989;18:2335.
2. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T,
Isenberg HD. Genotypic variation and slime production
among blood and catheter isolates of Candida parapsilosis.
J Clin Microbiol 1994;32:4526.
3. Samaranayake LP, Cheung LK, Samaranayake YH. Candidiasis and other fungal diseases of the mouth. Dermatol Ther
2002;15:25270.
4. Edgerton M, Scannapieco FA, Reddy MS, Levine MJ. Human
submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect Immunol
1993;61:264452.
5. Nikawa H, Nishimura H, Hamada T, Kumagai H, Samaranayake LP. Effects of dietary sugars and, saliva and serum
on Candida biofilm formation on acrylic surfaces. Mycopathologia 1997;139:8791.
6. McCourtie J, MacFarlane TW, Samaranayake LP. Effect of
saliva and serum on the adherence of Candida species to
chiorhexidine-treated denture acrylic. J Med Microbiol
1986;21:20913.
7. Samaranayake LP, MacFarlane TW. An in vitro study of the
adherence of Candida albicans to acrylic surfaces. Arch Oral
Biol 1980;25:6039.
797
8. San Milla
n R, Elguezabal N, Regu
lez P, Moragues MD,
Quindo
s G, Ponto
n J. Effect of salivary secretary IgA on
the adhesion of Candida albicans to polystyrene. Microbiology 2000;146:210512.
9. Samaranayake LP. Nutritional factors and oral candidosis. J
Oral Pathol 1986;15:615.
10. Gross KC, Acosta PB. Fruits and vegetables are a source of
galactose: implications in planning the diets of patients with
galactosaemia. J Inherit Metabol Dis 1991;14:2538.
11. Gropper SS, Weese JO, West PA, Gross KC. Free galactose
content of fresh fruits and strained fruit and vegetable baby
foods: more foods to consider for the galactose-restricted
diet. J Am Diet Assoc 2000;100:5735.
12. McCourtie J, Douglas LJ. Relationship between cell surface
composition, adherence, and virulence of Candida albicans.
Infect Immunol 1984;45:612.
13. Hawser SP, Douglas LJ. Biofilm formation by Candida species
on the surface of catheter materials in vitro. Infect Immunol
1994;62:91521.
14. Samaranayake LP, MacFarlane TW. The effect of dietary
carbohydrates on the in vitro adhesion of Candida albicans
to epithelial cells. J Med Microbiol 1982;15:5117.
15. Hawser S. Comparisons of the susceptibilities of planktonic
and adherent Candida albicans to antifungal agents: a
modified XTT tetrazolium assay using synchronized C.
albicans cells. J Med Vet Mycol 1996;34:14952.
16. Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP.
Biofilm forming ability of Candida albicans is unlikely to
contribute to high oral yeast carriage in human immunodeficiency virus-infection. J Clin Microbiol 2003;41:29617.
17. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum
MA. Antifungal susceptibility of Candida biofilms: unique
efficacy of amphotericin B lipid formulations and echinocandins. Antimicrobiol Agents Chemother 2002;46:1773
80.
18. Tellier R, Krajden M, Grigoriew GA, Campbell I. Innovative
endpoint determination system for antifungal susceptibility
testing of yeasts. Antimicrobiol Agents Chemother
1992;36:161925.
19. Gracia E, Ferna
ndez A, Conchello P, Alabart JL, Pe
rez M,
Amorena B. In vitro development of Staphylococcus aureus
biofilms using slime-producing variants and ATP-bioluminescence for automated bacterial quantification. Luminescence 1999;14:2331.
20. Samaranayake YH, Samaranayake LP, Pow EH, Beena VT,
Yeung KW. Antifungal effects of lysozyme and lactoferrin
against genetically similar, sequential Candida albicans
isolates from a human immunodeficiency virus-infected
southern Chinese cohort. J Clin Microbiol 2001;39:
3296302.
21. Veerman EC, van den Keybus PA, Vissink A, Nieuw
Amerongen AV. Human glandular salivas: their separate
collection and analysis. Eur J Oral Sci 1996;104:34652.
22. Zipkes MR, Gilchrist JE, Peeler JT. Comparison of yeast and
mold counts by spiral, pour, and streak plate methods. J
Assoc Off Anal Chem 1981;64:14659.
23. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA.
Comparison of biofilms formed by Candida albicans and
Candida parapsilosis on bioprosthetic surfaces. Infect
Immunol 2002;70:87888.
24. Ramage G, Vande Walle K, Wickes BL, Lo
pez-Ribot JL.
Standardized method for in vitro antifungal susceptibility
testing of Candida albicans biofilms. Antimicrobiol Agents
Chemother 2001;45:24759.
25. Wentland EJ, Huang CT, McFeters GA. Spatial variations in
growth rate within Klebsiella pneumoniae colonies and
biofilm. Biotechnol Prog 1996;12:31621.
798
26. Taylor AL, Kudlow BA, Marrs KL, Gruenert DC, Guggino WB,
Schwiebert EM. Bioluminescence detection of ATP release
mechanisms in epithelia. Am J Physiol 1998;275:1391406.
27. Nikawa H, Egusa H, Makihira S, Yamashiro H, Fukushima H,
Jin C, et al. Alteration of the coadherence of Candida
albicans with oral bacteria by dietary sugars. Oral Microbiol
Immunol 2001;16:27983.
28. Sakakibara T, Murakami S, Hattori N, Nakajima M, Imai K.
Enzymatic treatment to eliminate the extracellular ATP for
improving the detectability of bacterial intracellular ATP.
Anal Biochem 1997;250:15761.
29. Douglas LJ. Mannoprotein adhesins of Candida albicans. In:
Bennett JE, Hay RJ, Peterson PK, editors. New strategies in
fungal disease. Edinburgh: Churchill Livingstone; 1992.
p. 3450.
30. McCourtie J, Douglas LJ. Extracellular polymer of Candida
albicans: isolation, analysis and role in adhesion. J Gen
Microbiol 1985;131:495503.
31. Hawser SP, Baillie GS, Douglas LJ. Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 1998;47:2536.
Y. Jin et al.